Filing Details

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND

(d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2

 

(Amendment No. )*

Acumen Pharmaceuticals, Inc.

(Name of Issuer)

 

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

 

00509G209

(CUSIP Number)

 

December 31, 2021

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐

Rule 13d-1(b)

☐

Rule 13d-1(c)

☒

Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

CUSIP No. 00509G209

13G

Page 2 of 8 Pages

1	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Paul B. Manning
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 3,352,6931
	6	SHARED VOTING POWER 657,9852
	7	SOLE DISPOSITIVE POWER 3,352,6931
	8	SHARED DISPOSITIVE POWER 657,9852

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,010,6783
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.9%4
12	TYPE OF REPORTING PERSON* IN

	1	Consists of: (i) 312,500 shares of the Issuer's common stock held by Paul and Diane Manning, JTWROS and (ii) 3,040,193 shares of the Issuer's common stock held by The Paul B. Manning Revocable Trust dated May 10, 2000.
	2	The securities are held by BKB Growth Investments, LLC.
	3	Consists of: (i) 312,500 shares of the Issuer's common stock held by Paul and Diane Manning, JTWROS; (ii) 3,040,193 shares of the Issuer’s common stock held directly by The Paul B. Manning Revocable Trust dated May 10, 2000; and (iii) 657,985 shares of the Issuer’s common stock held by BKB Growth Investments, LLC.

4

This percentage is calculated based upon 40,470,323 shares of the Issuer’s common stock outstanding as of November 15, 2021, as reported by the Issuer in its Form 10-Q for the quarter ended September 30, 2021, filed with the Securities and Exchange Commission on November 15, 2021.

CUSIP No. 00509G209			13G	Page 3 of 8 Pages
	1	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) The Paul B. Manning Revocable Trust dated May 10, 2000
	2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☐
	3	SEC USE ONLY
	4	CITIZENSHIP OR PLACE OF ORGANIZATION Virginia

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 3,040,193
	6	SHARED VOTING POWER 0
	7	SOLE DISPOSITIVE POWER 3,040,193
	8	SHARED DISPOSITIVE POWER 0

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,040,193
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.5%5
12	TYPE OF REPORTING PERSON* OO

5

This percentage is calculated based upon 40,470,323 shares of the Issuer’s common stock outstanding as of November 15, 2021, as reported by the Issuer in its Form 10-Q for the quarter ended September 30, 2021, filed with the Securities and Exchange Commission on November 15, 2021.

CUSIP No. 00509G209

13G

Page 4 of 8 Pages

1	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) BKB Growth Investments, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5	SOLE VOTING POWER 657,985
	6	SHARED VOTING POWER 0
	7	SOLE DISPOSITIVE POWER 657,985
	8	SHARED DISPOSITIVE POWER 0

9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 657,985
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.6%6
12	TYPE OF REPORTING PERSON* OO

6

This percentage is calculated based upon 40,470,323 shares of the Issuer’s common stock outstanding as of November 15, 2021, as reported by the Issuer in its Form 10-Q for the quarter ended September 30, 2021, filed with the Securities and Exchange Commission on November 15, 2021.

CUSIP No. 00509G209

13G

Page 5 of 8 Pages

Item 1.

 

(a)

Name of Issuer

Acumen Pharmaceuticals, Inc.

 

(b)

Address of Issuer’s Principal Executive Offices

427 Park St.
Charlottesville, VA 22902

Item 2.

 

(a)

Name of Person Filing

Paul B. Manning
The Paul B. Manning Revocable Trust dated May 10, 2000

BKB Growth Investments, LLC

 

(b)

Address of Principal Business Office or, if none, Residence

c/o PBM Capital Group, LLC
200 Garrett Street, Suite S
Charlottesville, VA 22902

 

(c)

Citizenship

Paul B. Manning is a United States Citizen.
The Paul B. Manning Revocable Trust dated May 10, 2000 is governed under the laws of the Commonwealth of Virginia.

BKB Growth Investments, LLC is a Delaware limited liability company.

 

(d)

Title of Class of Securities

Common Stock

 

(e)

CUSIP Number

00509G209

 

Item 3.	If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: NOT APPLICABLE.

(a)	☐	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)	☐	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c)	☐	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

CUSIP No. 00509G209

13G

Page 6 of 8 Pages

(d)	☐	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
(e)	☐	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)	☐	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)	☐	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	☐	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	☐	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	☐	A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
(k)	☐	Group, in accordance with §240.13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

 

Item 4.	Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

	(a)	Amount beneficially owned: See responses to Item 9 on the attached cover pages.
	(b)	Percent of class: See the responses to Item 11 on the attached cover pages.
	(c)	Number of shares as to which the person has:
			(i)	Sole power to vote or to direct the vote – See the responses to Item 5 on the attached cover pages.
			(ii)	Shared power to vote or to direct the vote – See the responses to Item 6 on the attached cover pages.
			(iii)	Sole power to dispose or to direct the disposition of – See the responses to Item 7 on the attached cover pages.
			(iv)	Shared power to dispose or to direct the disposition of – See the responses to Item 8 on the attached cover pages.

Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

 

Item 5.	Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

 

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable

CUSIP No. 00509G209

13G

Page 7 of 8 Pages

	Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not Applicable

 

	Item 8.	Identification and Classification of Members of the Group.

Not Applicable

 

	Item 9.	Notice of Dissolution of Group.

Not Applicable

 

	Item 10.	Certification

Not Applicable.

CUSIP No. 00509G209

13G

Page 8 of 8 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

February 14, 2022
	/s/ Paul B. Manning
	Paul B. Manning
	The Paul B. Manning Revocable Trust Dated May 10, 2000
	By:	/s/ Paul B. Manning
	Name:	Paul B. Manning
	Title:	Trustee
	BKB Growth Investments, LLC
	By Tiger Lily Capital, LLC, its manager
	By:	/s/ Paul B. Manning
	Name:	Paul B. Manning
	Title:	Manager
	By:	/s/ Bradford Manning
	Name:	Bradford Manning
	Title:	Manager